Cellebrite DI Ltd. (CLBT) Cash flow
Market cap
P/E ratio
| 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Depreciation & amortization | 7 | 9 | 10 | 11 |
| Stock-based compensation | 6 | 14 | 19 | 31 |
| Cash from operations | 36 | 21 | 102 | 132 |
| Capital expenditures | -5 | -7 | -5 | -9 |
| Cash from investing | 45 | -91 | -23 | -149 |
| Payments for dividends | 100 | - | - | - |
| Cash from financing | -68 | 14 | 22 | 21 |
| Free cash flow | ||||
| FCF margin (%) |